应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
MEIP MEI Pharma
未开盘 07-10 16:00:00 EDT
2.69
-0.06
-2.18%
盘后
2.69
+0.00
0.00%
19:57 EDT
最高
2.80
最低
2.65
成交量
8,221
今开
2.75
昨收
2.75
日振幅
5.38%
总市值
1,792万
流通市值
1,328万
总股本
666.29万
成交额
2.27万
换手率
0.17%
流通股本
493.86万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Mei Pharma, Inc.盘中异动 下午盘快速上涨5.38%
市场透视 · 07-09 19:07
Mei Pharma, Inc.盘中异动 下午盘快速上涨5.38%
Mei Pharma, Inc.盘中异动 急速上涨5.06%
市场透视 · 07-01
Mei Pharma, Inc.盘中异动 急速上涨5.06%
Mei Pharma, Inc.盘中异动 股价大涨5.36%
市场透视 · 06-30
Mei Pharma, Inc.盘中异动 股价大涨5.36%
Mei Pharma, Inc.盘中异动 下午盘股价大涨5.43%报2.33美元
市场透视 · 06-10
Mei Pharma, Inc.盘中异动 下午盘股价大涨5.43%报2.33美元
Mei Pharma, Inc.盘中异动 急速跳水6.24%报2.10美元
市场透视 · 06-02
Mei Pharma, Inc.盘中异动 急速跳水6.24%报2.10美元
Mei Pharma, Inc.盘中异动 早盘大幅下跌5.25%报2.08美元
市场透视 · 05-30
Mei Pharma, Inc.盘中异动 早盘大幅下跌5.25%报2.08美元
Mei Pharma, Inc.盘中异动 大幅上涨5.77%
市场透视 · 05-20
Mei Pharma, Inc.盘中异动 大幅上涨5.77%
Mei Pharma, Inc.2025财年第一财季实现净利润-2.57百万美元,同比增加71.85%
市场透视 · 05-19
Mei Pharma, Inc.2025财年第一财季实现净利润-2.57百万美元,同比增加71.85%
Mei Pharma, Inc.盘中异动 临近午盘股价大跌5.41%
市场透视 · 05-15
Mei Pharma, Inc.盘中异动 临近午盘股价大跌5.41%
Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元
市场透视 · 05-14
Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元
Mei Pharma, Inc.盘中异动 早盘股价大涨5.97%
市场透视 · 04-29
Mei Pharma, Inc.盘中异动 早盘股价大涨5.97%
Mei Pharma, Inc.盘中异动 下午盘快速上涨5.05%报2.08美元
市场透视 · 04-24
Mei Pharma, Inc.盘中异动 下午盘快速上涨5.05%报2.08美元
Mei Pharma, Inc.盘中异动 早盘急速拉升6.28%报2.03美元
市场透视 · 04-15
Mei Pharma, Inc.盘中异动 早盘急速拉升6.28%报2.03美元
Mei Pharma, Inc.盘中异动 大幅下挫5.34%
市场透视 · 03-06
Mei Pharma, Inc.盘中异动 大幅下挫5.34%
Mei Pharma, Inc.盘中异动 下午盘大幅拉升5.23%报2.74美元
市场透视 · 02-24
Mei Pharma, Inc.盘中异动 下午盘大幅拉升5.23%报2.74美元
Mei Pharma, Inc.盘中异动 早盘股价大跌6.41%报2.55美元
市场透视 · 02-14
Mei Pharma, Inc.盘中异动 早盘股价大跌6.41%报2.55美元
MEI Pharma第二季度每股收益$(0.40),同比上涨$(1.66)
财报速递 · 02-12
MEI Pharma第二季度每股收益$(0.40),同比上涨$(1.66)
Mei Pharma, Inc.盘中异动 早盘快速跳水5.69%报2.65美元
市场透视 · 02-07
Mei Pharma, Inc.盘中异动 早盘快速跳水5.69%报2.65美元
Mei Pharma, Inc.盘中异动 股价大涨5.77%
市场透视 · 01-08
Mei Pharma, Inc.盘中异动 股价大涨5.77%
Mei Pharma, Inc.盘中异动 股价大涨5.88%报2.70美元
市场透视 · 01-03
Mei Pharma, Inc.盘中异动 股价大涨5.88%报2.70美元
加载更多
公司概况
公司名称:
MEI Pharma
所属市场:
NASDAQ
上市日期:
--
主营业务:
MEI Pharma, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。
发行价格:
--
{"stockData":{"symbol":"MEIP","market":"US","secType":"STK","nameCN":"MEI Pharma","latestPrice":2.69,"timestamp":1752177600000,"preClose":2.75,"halted":0,"volume":8221,"hourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.69,"latestTime":"19:57 EDT","volume":7,"amount":18.77,"timestamp":1752191820446},"delay":0,"floatShares":4938598,"shares":6662857,"eps":-4.752063,"marketStatus":"未开盘","change":-0.06,"latestTime":"07-10 16:00:00 EDT","open":2.75,"high":2.7995,"low":2.6515,"amount":22693.3585614,"amplitude":0.053818,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.752063,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752220800000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1071723600000,"exchange":"NASDAQ","adjPreClose":2.75,"preHourTrading":{"tag":"盘前","latestPrice":2.64,"preClose":2.75,"latestTime":"08:37 EDT","volume":51,"amount":134.610012,"timestamp":1752151029800},"postHourTrading":{"tag":"盘后","latestPrice":2.69,"preClose":2.69,"latestTime":"19:57 EDT","volume":7,"amount":18.77,"timestamp":1752191820446},"volumeRatio":0.446158,"impliedVol":0.9983,"impliedVolPercentile":0.732},"requestUrl":"/m/hq/s/MEIP","defaultTab":"news","newsList":[{"id":"2550650288","title":"Mei Pharma, Inc.盘中异动 下午盘快速上涨5.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550650288","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550650288?lang=zh_cn&edition=full","pubTime":"2025-07-10 03:07","pubTimestamp":1752088069,"startTime":"0","endTime":"0","summary":"北京时间2025年07月10日03时07分,Mei Pharma, Inc.股票出现异动,股价急速拉升5.38%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为1.36%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710030749953c79fc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250710030749953c79fc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2548867008","title":"Mei Pharma, Inc.盘中异动 急速上涨5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548867008","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548867008?lang=zh_cn&edition=full","pubTime":"2025-07-02 00:45","pubTimestamp":1751388304,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日00时45分,Mei Pharma, Inc.股票出现波动,股价大幅上涨5.06%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.90%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004504979621e7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702004504979621e7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2547138540","title":"Mei Pharma, Inc.盘中异动 股价大涨5.36%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547138540","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547138540?lang=zh_cn&edition=full","pubTime":"2025-06-30 22:50","pubTimestamp":1751295027,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日22时50分,Mei Pharma, Inc.股票出现异动,股价大幅拉升5.36%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.77%。其相关个股中,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Vor Biopharma Inc.涨幅较大,Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Inmune Bio Inc.较为活跃,换手率分别为3645.54%、297.77%、98.79%,振幅较大的相关个股有Artelo Biosciences, Inc.、Klotho Neurosciences, Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 ,振幅分别为117.82%、56.94%、50.00%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302250289794b878&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202506302250289794b878&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2542344938","title":"Mei Pharma, Inc.盘中异动 下午盘股价大涨5.43%报2.33美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2542344938","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2542344938?lang=zh_cn&edition=full","pubTime":"2025-06-11 02:17","pubTimestamp":1749579429,"startTime":"0","endTime":"0","summary":"北京时间2025年06月11日02时17分,Mei Pharma, Inc.股票出现异动,股价大幅上涨5.43%。截至发稿,该股报2.33美元/股,成交量6809股,换手率0.10%,振幅7.18%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.83%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611021710a4a249e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250611021710a4a249e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2540950957","title":"Mei Pharma, Inc.盘中异动 急速跳水6.24%报2.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2540950957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2540950957?lang=zh_cn&edition=full","pubTime":"2025-06-02 21:39","pubTimestamp":1748871575,"startTime":"0","endTime":"0","summary":"北京时间2025年06月02日21时39分,Mei Pharma, Inc.股票出现异动,股价大幅跳水6.24%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.89%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213936976e8257&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250602213936976e8257&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2539835273","title":"Mei Pharma, Inc.盘中异动 早盘大幅下跌5.25%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2539835273","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2539835273?lang=zh_cn&edition=full","pubTime":"2025-05-30 21:58","pubTimestamp":1748613532,"startTime":"0","endTime":"0","summary":"北京时间2025年05月30日21时58分,Mei Pharma, Inc.股票出现波动,股价急速下挫5.25%。截至发稿,该股报2.08美元/股,成交量118股,换手率0.00%,振幅0.00%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为3.75%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215853a492f65d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250530215853a492f65d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2537644488","title":"Mei Pharma, Inc.盘中异动 大幅上涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2537644488","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537644488?lang=zh_cn&edition=full","pubTime":"2025-05-21 00:09","pubTimestamp":1747757395,"startTime":"0","endTime":"0","summary":"北京时间2025年05月21日00时09分,Mei Pharma, Inc.股票出现波动,股价快速拉升5.77%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.23%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大,Polyrizon Ltd.、Eyenovia, Inc.、Neuraxis, Inc.较为活跃,换手率分别为4287.88%、1552.03%、1081.53%,振幅较大的相关个股有Nls Pharmaceutics Ltd C/Wts 02/02/2026、Neuraxis, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为174.55%、100.00%、95.65%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521000956aa2c944d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521000956aa2c944d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4139","NRXS","MEIP"],"gpt_icon":0},{"id":"2536636600","title":"Mei Pharma, Inc.2025财年第一财季实现净利润-2.57百万美元,同比增加71.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536636600","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536636600?lang=zh_cn&edition=full","pubTime":"2025-05-20 00:00","pubTimestamp":1747670431,"startTime":"0","endTime":"0","summary":"5月20日,Mei Pharma, Inc.公布财报,公告显示公司2025财年第一财季净利润为-2.57百万美元,同比增加71.85%;其中营业收入为0.00美元,每股基本收益为-0.39美元。从资产负债表来看,Mei Pharma, Inc.总负债1.24百万美元,其中短期债务0.00美元,资产负债比为16.76,流动比率为16.76。机构评级:截至2025年5月20日,当前有3家机构对Mei Pharma, Inc.目标价做出预测,其中目标均价为22.67美元,其中最低目标价为6.00美元,最高目标价为42.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000039a4844397&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520000039a4844397&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP"],"gpt_icon":0},{"id":"2535558873","title":"Mei Pharma, Inc.盘中异动 临近午盘股价大跌5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2535558873","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535558873?lang=zh_cn&edition=full","pubTime":"2025-05-15 23:34","pubTimestamp":1747323268,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日23时34分,Mei Pharma, Inc.股票出现波动,股价大幅跳水5.41%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为1.16%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515233428975ad6ee&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515233428975ad6ee&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2535007702","title":"Mei Pharma, Inc.盘中异动 大幅上涨7.64%报2.25美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535007702","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535007702?lang=zh_cn&edition=full","pubTime":"2025-05-15 00:06","pubTimestamp":1747238766,"startTime":"0","endTime":"0","summary":"北京时间2025年05月15日00时06分,Mei Pharma, Inc.股票出现异动,股价大幅拉升7.64%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.08%。其相关个股中,Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Liminatus Pharma Inc C/Wts 30/04/2030 涨幅较大,Polyrizon Ltd.、Nucana Plc、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为4091.82%、3985.55%、1556.07%,振幅较大的相关个股有Klotho Neurosciences, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Onconetix, Inc.,振幅分别为339.54%、201.95%、135.53%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025051500060694f6e58b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2531169756","title":"Mei Pharma, Inc.盘中异动 早盘股价大涨5.97%","url":"https://stock-news.laohu8.com/highlight/detail?id=2531169756","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2531169756?lang=zh_cn&edition=full","pubTime":"2025-04-29 22:17","pubTimestamp":1745936274,"startTime":"0","endTime":"0","summary":"北京时间2025年04月29日22时17分,Mei Pharma, Inc.股票出现异动,股价快速上涨5.97%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为1.53%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042922175494e7a97b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025042922175494e7a97b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2530966236","title":"Mei Pharma, Inc.盘中异动 下午盘快速上涨5.05%报2.08美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2530966236","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2530966236?lang=zh_cn&edition=full","pubTime":"2025-04-25 02:17","pubTimestamp":1745518620,"startTime":"0","endTime":"0","summary":"北京时间2025年04月25日02时17分,Mei Pharma, Inc.股票出现异动,股价急速上涨5.05%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.38%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021700a6c6f858&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250425021700a6c6f858&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2527443472","title":"Mei Pharma, Inc.盘中异动 早盘急速拉升6.28%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2527443472","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2527443472?lang=zh_cn&edition=full","pubTime":"2025-04-15 22:26","pubTimestamp":1744727196,"startTime":"0","endTime":"0","summary":"北京时间2025年04月15日22时26分,Mei Pharma, Inc.股票出现异动,股价快速拉升6.28%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.14%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152226379738b46b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202504152226379738b46b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2517957981","title":"Mei Pharma, Inc.盘中异动 大幅下挫5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517957981","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517957981?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:47","pubTimestamp":1741283242,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时47分,Mei Pharma, Inc.股票出现异动,股价急速跳水5.34%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.91%。其相关个股中,Plus Therapeutics, Inc.、Aeon Biopharma, Inc.、Cardio Diagnostics Holdings Inc C/Wts To Pur Com涨幅较大,Aeon Biopharma, Inc.、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.较为活跃,换手率分别为4011.68%、3242.95%、232.72%,振幅较大的相关个股有Surrozen Inc C/Wts 01/08/2031 、Plus Therapeutics, Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为125.28%、122.63%、71.44%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014722a262bfc9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307014722a262bfc9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2514703853","title":"Mei Pharma, Inc.盘中异动 下午盘大幅拉升5.23%报2.74美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514703853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514703853?lang=zh_cn&edition=full","pubTime":"2025-02-25 04:17","pubTimestamp":1740428222,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日04时17分,Mei Pharma, Inc.股票出现异动,股价急速上涨5.23%。截至发稿,该股报2.74美元/股,成交量2499股,换手率0.04%,振幅6.77%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.24%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。该公司的临床候选药物包括 Pracinostat,这是一种用于治疗急性髓性白血病和骨髓增生异常综合征患者的口服组蛋白脱乙酰酶抑制剂。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041702a2525ced&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225041702a2525ced&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2511369421","title":"Mei Pharma, Inc.盘中异动 早盘股价大跌6.41%报2.55美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511369421","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511369421?lang=zh_cn&edition=full","pubTime":"2025-02-14 23:29","pubTimestamp":1739546941,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日23时29分,Mei Pharma, Inc.股票出现异动,股价急速下挫6.41%。截至发稿,该股报2.55美元/股,成交量263股,换手率0.00%,振幅0.00%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.11%。其相关个股中,Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cns Pharmaceuticals, Inc.涨幅较大,Moleculin Biotech, Inc.、Cns Pharmaceuticals, Inc.、Virpax Pharmaceuticals, Inc.较为活跃,换手率分别为2475.82%、641.94%、479.68%,振幅较大的相关个股有Moleculin Biotech, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Klotho Neurosciences Inc C/Wts 21/06/2029 ,振幅分别为66.93%、54.40%、43.67%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232901abcf13bf&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214232901abcf13bf&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"1126269653","title":"MEI Pharma第二季度每股收益$(0.40),同比上涨$(1.66)","url":"https://stock-news.laohu8.com/highlight/detail?id=1126269653","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126269653?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:40","pubTimestamp":1739396421,"startTime":"0","endTime":"0","summary":"MEI Pharma(NASDAQ:MEIP)报告季度每股亏损$(0.40)。这比去年同期的每股亏损$(1.66)增长了75.9%。以上内容来自Benzinga Earnings专栏,原文如下:$MEI Pharma(MEIP)$ (NASDAQ:MEIP) reported quarterly losses of $(0.40) per share. This is a 75.9 percent increase over losses of $(1.66) per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEIP","MEI"],"gpt_icon":0},{"id":"2509613723","title":"Mei Pharma, Inc.盘中异动 早盘快速跳水5.69%报2.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509613723","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509613723?lang=zh_cn&edition=full","pubTime":"2025-02-07 23:56","pubTimestamp":1738943793,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日23时56分,Mei Pharma, Inc.股票出现异动,股价快速跳水5.69%。Mei Pharma, Inc.股票所在的生物技术行业中,整体跌幅为0.36%。其相关个股中,Conduit Pharmaceuticals Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.、Lipella Pharmaceuticals Inc.较为活跃,换手率分别为4353.65%、152.61%、93.94%,振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Conduit Pharmaceuticals Inc.、Tonix Pharmaceuticals Holding Corp.,振幅分别为130.43%、60.00%、53.38%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207235633abc63de0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207235633abc63de0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","MEIP"],"gpt_icon":0},{"id":"2502703732","title":"Mei Pharma, Inc.盘中异动 股价大涨5.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2502703732","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2502703732?lang=zh_cn&edition=full","pubTime":"2025-01-09 01:23","pubTimestamp":1736356997,"startTime":"0","endTime":"0","summary":"北京时间2025年01月09日01时23分,Mei Pharma, Inc.股票出现异动,股价急速上涨5.77%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.28%。其相关个股中,Sana Biotechnology, Inc.、Silo Pharma, Inc.、Vir Biotechnology, Inc.涨幅较大,Silo Pharma, Inc.、Nls Pharmaceutics Ltd.、60 Degrees Pharmaceuticals, Inc.较为活跃,换手率分别为3423.37%、591.70%、586.94%,振幅较大的相关个股有Sana Biotechnology, Inc.、Silo Pharma, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028,振幅分别为192.73%、143.11%、89.00%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012318985f9569&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250109012318985f9569&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0},{"id":"2500432021","title":"Mei Pharma, Inc.盘中异动 股价大涨5.88%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2500432021","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2500432021?lang=zh_cn&edition=full","pubTime":"2025-01-04 00:01","pubTimestamp":1735920072,"startTime":"0","endTime":"0","summary":"北京时间2025年01月04日00时01分,Mei Pharma, Inc.股票出现异动,股价快速上涨5.88%。Mei Pharma, Inc.股票所在的生物技术行业中,整体涨幅为0.44%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.涨幅较大,Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.、Onconetix, Inc.较为活跃,换手率分别为1668.08%、1449.75%、304.85%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Scorpius Holdings, Inc.、Cyclacel Pharmaceuticals, Inc.,振幅分别为143.91%、107.01%、97.79%。Mei Pharma, Inc.公司简介:MEI Pharma Inc 专注于癌症新疗法的临床开发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104000112a2147c3e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250104000112a2147c3e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MEIP","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.meipharma.com","stockEarnings":[{"period":"1week","weight":0.0037},{"period":"1month","weight":0.1696},{"period":"3month","weight":0.4385},{"period":"6month","weight":-0.0037},{"period":"1year","weight":-0.0358},{"period":"ytd","weight":0.0935}],"compareEarnings":[{"period":"1week","weight":0.0008},{"period":"1month","weight":0.0377},{"period":"3month","weight":0.1721},{"period":"6month","weight":0.0781},{"period":"1year","weight":0.1149},{"period":"ytd","weight":0.0678}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"MEI Pharma, Inc.是一家临床阶段的制药公司,致力于开发新型和差异化的癌症疗法。该公司通过收购有前途的癌症药物来建立管道,并通过临床开发、战略合作伙伴关系以及外包许可或商业化(视情况而定)在项目中创造价值。候选药物包括口服细胞周期蛋白依赖性激酶9抑制剂voruciclib和靶向氧化磷酸化途径的静脉注射小分子线粒体抑制剂ME-344。","yearOnYearQuotes":[{"month":1,"riseRate":0.454545,"avgChangeRate":0.061622},{"month":2,"riseRate":0.409091,"avgChangeRate":-0.005853},{"month":3,"riseRate":0.409091,"avgChangeRate":-0.074385},{"month":4,"riseRate":0.545455,"avgChangeRate":0.020025},{"month":5,"riseRate":0.454545,"avgChangeRate":0.039254},{"month":6,"riseRate":0.363636,"avgChangeRate":-0.082941},{"month":7,"riseRate":0.363636,"avgChangeRate":0.031639},{"month":8,"riseRate":0.4,"avgChangeRate":-0.008632},{"month":9,"riseRate":0.55,"avgChangeRate":0.077177},{"month":10,"riseRate":0.4,"avgChangeRate":-0.06033},{"month":11,"riseRate":0.45,"avgChangeRate":-0.037118},{"month":12,"riseRate":0.238095,"avgChangeRate":0.017657}],"exchange":"NASDAQ","name":"MEI Pharma","nameEN":"MEI Pharma"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"MEI Pharma,MEIP,MEI Pharma股票,MEI Pharma股票老虎,MEI Pharma股票老虎国际,MEI Pharma行情,MEI Pharma股票行情,MEI Pharma股价,MEI Pharma股市,MEI Pharma股票价格,MEI Pharma股票交易,MEI Pharma股票购买,MEI Pharma股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"MEI Pharma(MEIP)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供MEI Pharma(MEIP)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}